These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 22213642

  • 1. Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients.
    Chao YK, Chuang WY, Yeh CJ, Wu YC, Liu YH, Hsieh MJ, Cheng AJ, Hsueh C, Liu HP.
    J Surg Oncol; 2012 Feb; 105(2):183-8. PubMed ID: 22213642
    [Abstract] [Full Text] [Related]

  • 2. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
    Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu YC, Kuo SY, Hsieh MJ, Hsueh C.
    J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
    [Abstract] [Full Text] [Related]

  • 3. COX2 expression predicts resistance to chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y, Hanari N, Yusup G, Komatsu-Akimoto A, Ikeda N, Mori M, Yoneyama Y, Endo S, Miyazawa Y, Matsubara H.
    Ann Surg Oncol; 2011 Oct; 18(10):2946-51. PubMed ID: 21437756
    [Abstract] [Full Text] [Related]

  • 4. Podoplanin and SOX2 expression in esophageal squamous cell carcinoma after neoadjuvant chemo-radiotherapy.
    Saigusa S, Mohri Y, Ohi M, Toiyama Y, Ishino Y, Okugawa Y, Tanaka K, Inoue Y, Kusunoki M.
    Oncol Rep; 2011 Nov; 26(5):1069-74. PubMed ID: 21811761
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK, Chan SC, Liu YH, Chen HW, Wan YL, Chang HK, Fan KH, Liu HP.
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer.
    Duong C, Greenawalt DM, Kowalczyk A, Ciavarella ML, Raskutti G, Murray WK, Phillips WA, Thomas RJ.
    Ann Surg Oncol; 2007 Dec; 14(12):3602-9. PubMed ID: 17896157
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.
    Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865
    [Abstract] [Full Text] [Related]

  • 10. Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Kawasaki Y, Okumura H, Uchikado Y, Kita Y, Sasaki K, Owaki T, Ishigami S, Natsugoe S.
    Ann Surg Oncol; 2014 Jul 15; 21(7):2347-52. PubMed ID: 24599410
    [Abstract] [Full Text] [Related]

  • 11. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R, Kitajima Y, Yunotani S, Miyazaki K.
    Anticancer Res; 1999 Jul 15; 19(6C):5515-21. PubMed ID: 10697609
    [Abstract] [Full Text] [Related]

  • 12. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
    Sano A, Kato H, Sakurai S, Sakai M, Tanaka N, Inose T, Saito K, Sohda M, Nakajima M, Nakajima T, Kuwano H.
    Ann Surg Oncol; 2009 Feb 15; 16(2):506-14. PubMed ID: 19050962
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma.
    Yang B, Rice TW, Adelstein DJ, Rybicki LA, Goldblum JR.
    Mod Pathol; 1999 Mar 15; 12(3):251-6. PubMed ID: 10102609
    [Abstract] [Full Text] [Related]

  • 14. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma.
    Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM.
    Am J Clin Pathol; 2007 Dec 15; 128(6):1002-9. PubMed ID: 18024326
    [Abstract] [Full Text] [Related]

  • 15. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.
    Ann Surg Oncol; 2010 May 15; 17(5):1311-23. PubMed ID: 20066519
    [Abstract] [Full Text] [Related]

  • 16. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
    Chao YK, Wu YC, Liu YH, Tseng CK, Chang HK, Hsieh MJ, Chu Y, Liu HP.
    J Surg Oncol; 2010 Aug 01; 102(2):158-62. PubMed ID: 20648587
    [Abstract] [Full Text] [Related]

  • 17. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T, Yamasaki M, Miyata H, Yoshioka S, Takiguchi S, Fujiwara Y, Nakajima K, Nishida T, Mori M, Doki Y.
    Ann Surg Oncol; 2010 Mar 01; 17(3):804-11. PubMed ID: 19885698
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens.
    Kii T, Takiuchi H, Kawabe S, Gotoh M, Ohta S, Tanaka T, Kuwakado S, Nishitani H, Katsu K.
    Jpn J Clin Oncol; 2007 Aug 01; 37(8):583-9. PubMed ID: 17709606
    [Abstract] [Full Text] [Related]

  • 19. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.
    Anticancer Res; 2002 Aug 01; 22(6C):3977-84. PubMed ID: 12553021
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y.
    Clin Cancer Res; 1999 Apr 01; 5(4):801-6. PubMed ID: 10213215
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.